A new audit from Health and Human Services’ Office of the Inspector General alleges that a Humana health plan for Florida seniors improperly collected almost $198 million in 2015 by failing to comply with some federal coding requirements and overstatin…
In a letter sent to the Centers for Medicare and Medicaid Services on Monday, the American Hospital Association said that there should be more suspensions on hospital surveys in the event of a surge in cases of COVID-19.
For much of the COVID-19 pandemic, Americans have had to go to established testing sites to be tested for the coronavirus, a process that can be time-consuming in driving time and wait times for both the test and the results. CVS Pharmacy, the retail a…
The Johnson & Johnson COVID-19 vaccine remains on pause due to concerns over several rare blood clotting cases that have developed in a handful of people who have received the vaccine, but scientists writing in the New England Journal of Medicine have …
Through the American Rescue Plan, the U.S. Department of Health and Human Services is making nearly $150 million available to community-based healthcare providers to use for COVID-19 response for underserved communities.
The funds will support approxi…
Dozens of provider groups, including America’s Physician Groups, American Academy of Home Care Medicine and VillageMD, have signed onto a letter imploring the Biden Administration to open up one more chance for providers to sign up for the Direct Contr…
COVID-19, against a background of growing awareness of health inequities, has expanded how we define population health. New laws, policies and funding have helped spur solutions.
The Federal Communications Commission’s Wireline Competition Bureau will begin accepting applications for Round 2 of the COVID-19 Telehealth Program on Thursday, April 29 at 12 p.m. ET.
The filing window will last seven days and close on Thursday, May …
Read the full post on News Feed
The pause on the use of the Johnson & Johnson vaccine will continue as a federal panel reviews the cases of six women who received the vaccine and developed blood clots.
